Songhui Xu

1.2k total citations
41 papers, 745 citations indexed

About

Songhui Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Songhui Xu has authored 41 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Songhui Xu's work include Ferroptosis and cancer prognosis (7 papers), Ubiquitin and proteasome pathways (7 papers) and Epigenetics and DNA Methylation (7 papers). Songhui Xu is often cited by papers focused on Ferroptosis and cancer prognosis (7 papers), Ubiquitin and proteasome pathways (7 papers) and Epigenetics and DNA Methylation (7 papers). Songhui Xu collaborates with scholars based in China, United States and Canada. Songhui Xu's co-authors include Guang‐Rong Yan, Jinzhou Huang, Jiaxi He, Qing‐Yu He, De Chen, A. James Mixson, Xiaolu Cui, Jianfei Qi, Fengbo Zhang and Lingling Fan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Songhui Xu

36 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Songhui Xu China 16 579 243 186 122 56 41 745
Verónica Torrano Spain 15 645 1.1× 233 1.0× 84 0.5× 117 1.0× 47 0.8× 20 772
Guoyin Li China 13 343 0.6× 230 0.9× 111 0.6× 156 1.3× 56 1.0× 35 584
Domenico Albino Switzerland 13 563 1.0× 254 1.0× 181 1.0× 209 1.7× 75 1.3× 23 773
Yongqing Gu China 15 357 0.6× 125 0.5× 140 0.8× 132 1.1× 50 0.9× 35 565
Naijun Han China 15 400 0.7× 222 0.9× 111 0.6× 202 1.7× 47 0.8× 31 689
Vijay Kumar Eedunuri United States 9 689 1.2× 398 1.6× 363 2.0× 106 0.9× 41 0.7× 13 951
Misty Shuo Zhang Hong Kong 10 467 0.8× 283 1.2× 167 0.9× 147 1.2× 72 1.3× 13 681
Carol Beesley United Kingdom 12 428 0.7× 258 1.1× 133 0.7× 87 0.7× 34 0.6× 13 567
Jeong‐Yeon Lee South Korea 17 600 1.0× 206 0.8× 101 0.5× 282 2.3× 63 1.1× 32 858
De Zeng China 15 392 0.7× 194 0.8× 127 0.7× 194 1.6× 58 1.0× 44 617

Countries citing papers authored by Songhui Xu

Since Specialization
Citations

This map shows the geographic impact of Songhui Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Songhui Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Songhui Xu more than expected).

Fields of papers citing papers by Songhui Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Songhui Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Songhui Xu. The network helps show where Songhui Xu may publish in the future.

Co-authorship network of co-authors of Songhui Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Songhui Xu. A scholar is included among the top collaborators of Songhui Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Songhui Xu. Songhui Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xiaoqiang, et al.. (2024). Trends in suicide mortality among prostate cancer survivors in the United States, 1975–2019. BMC Public Health. 24(1). 101–101. 4 indexed citations
2.
Zheng, Fu‐Chun, Sheng Li, Zhipeng Wang, et al.. (2024). The enigmatic interplay of immune cells and abnormal spermatozoa through Mendelian randomization. American Journal of Reproductive Immunology. 91(4). e13846–e13846. 1 indexed citations
3.
Li, Sheng, et al.. (2024). Integrated analysis of bulk and single‐cell RNA‐seq data reveals cell differentiation‐related subtypes and a scoring system in bladder cancer. Journal of Cellular and Molecular Medicine. 28(19). e70111–e70111. 2 indexed citations
4.
Zheng, Fu‐Chun, Sheng Li, Jin Zeng, et al.. (2024). Development of a propionate metabolism-related gene-based molecular subtypes and scoring system for predicting prognosis in bladder cancer. European journal of medical research. 29(1). 393–393. 2 indexed citations
5.
Li, Sheng, Zhongqi Li, Lin Yang, et al.. (2024). USP3 promotes DNA damage response and chemotherapy resistance through stabilizing and deubiquitinating SMARCA5 in prostate cancer. Cell Death and Disease. 15(11). 790–790. 4 indexed citations
6.
Li, Sheng, Zhongqi Li, Yanping Song, et al.. (2024). A noncanonical E3 ubiquitin ligase RNF41-mediated MYO1C stability promotes prostate cancer metastasis by inducing actin remodeling. Oncogene. 43(36). 2696–2707. 2 indexed citations
7.
Zheng, Fu‐Chun, et al.. (2024). Risk analysis of enfortumab vedotin: A real-world approach based on the FAERS database. Heliyon. 10(18). e37544–e37544. 1 indexed citations
9.
Dong, Wentao, Ming Jiang, Sheng Li, et al.. (2023). Value of the application of computed tomography‐based radiomics for preoperative prediction of unfavorable pathology in initial bladder cancer. Cancer Medicine. 12(15). 15868–15880. 3 indexed citations
10.
Yang, Lin, Jiahao Liu, Sheng Li, et al.. (2023). Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1. Journal of Cancer Research and Clinical Oncology. 149(12). 9787–9804. 26 indexed citations
11.
Chen, Tao, et al.. (2023). Causal relationship between prostate cancer and 12 types of cancers: multivariable and bidirectional Mendelian randomization analyses. International Urology and Nephrology. 56(2). 547–556. 1 indexed citations
12.
Yang, Lin, Xiaoyu Wang, Jiahao Liu, et al.. (2023). Prognostic and tumor microenvironmental feature of clear cell renal cell carcinoma revealed by m6A and lactylation modification-related genes. Frontiers in Immunology. 14. 1225023–1225023. 13 indexed citations
13.
Li, Sheng, Jin Zeng, Xiaoqiang Liu, et al.. (2023). Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB. Frontiers in Immunology. 14. 1253586–1253586. 4 indexed citations
14.
Sun, Lianhui, Xing Wang, Lixiao Chen, et al.. (2023). CPT1A mediates chemoresistance in human hypopharyngeal squamous cell carcinoma via ATG16L1-dependent cellular autophagy. SHILAP Revista de lepidopterología. 2(6). 100127–100127. 13 indexed citations
15.
He, Jiaxi, Songhui Xu, Hui Pan, Shuben Li, & Jianxing He. (2020). Does size matter? —a population-based analysis of malignant pleural mesothelioma. Translational Lung Cancer Research. 9(4). 1041–1052. 10 indexed citations
16.
He, Jiaxi, Songhui Xu, Hui Pan, Shuben Li, & Jianxing He. (2020). Treatments for combined small cell lung cancer patients. Translational Lung Cancer Research. 9(5). 1785–1794. 12 indexed citations
17.
Xu, Songhui, Song Zhu, Yanjie Wang, et al.. (2018). ECD promotes gastric cancer metastasis by blocking E3 ligase ZFP91-mediated hnRNP F ubiquitination and degradation. Cell Death and Disease. 9(5). 479–479. 26 indexed citations
18.
Yan, Guang‐Rong, et al.. (2011). Identification of novel signaling components in genistein-regulated signaling pathways by quantitative phosphoproteomics. Journal of Proteomics. 75(2). 695–707. 15 indexed citations
19.
Yan, Guang‐Rong, et al.. (2011). Proteomics characterization of gastrokine 1‐induced growth inhibition of gastric cancer cells. PROTEOMICS. 11(18). 3657–3664. 37 indexed citations
20.
Yan, Guang‐Rong, et al.. (2011). Global identification of miR‐373‐regulated genes in breast cancer by quantitative proteomics. PROTEOMICS. 11(5). 912–920. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026